Finland to prioritise FP7 agreement and boosting innovation during Presidency

EU PresidencyFinland has announced its priorities for research and innovation during its Presidency of the EU, started on 1 July: concluding negotiations on the Seventh Framework Programme (FP7); and developing a broad-based innovation policy.

The Presidency will kick-off its six months at the helm of the EU with an informal Competitiveness Council on 10 and 11 July in Jyväskylä, where it will present a background paper on innovation.

"I believe that innovation policy is very much the joint responsibility of all ministers responsible for the various strands of the Competitiveness Council and, during the meeting, would like to hear your views on the topic. It is my intention to take this theme forward together with the Commission during the autumn," writes Mauri Pekkarinen, Finland's Minister for Trade and Industry, in his letter of invitation.

The innovation policy that Finland wishes to promote will be based largely on the recommendations outlined in the expert group report, chaired by former Finnish Prime Minister Esko Aho, and prepared on behalf of the European Commission. "The basic point of departure is a broadening of perspectives to include the demand for innovation," states the Finnish government.

The way to improve the EU's innovation policy is to develop markets that encourage innovation and create new demand, states the Finnish priorities paper. Important factors listed include standards, public procurements, enhancing the efficient operation of the market, mobility of research resources, and closer cooperation between universities and businesses.

On research, Finland aims to conclude negotiations on FP7 so that the programme can be launched at the start of 2007. A formal Competitiveness Council will take place on 25 September.

Further information on the research and innovation activities of the Finnish Presidency will be available from 3 July at:
http://cordis.europa.eu/finland

For other information on the Finnish Presidency, please see:
http://www.eu2006.fi

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Cancer Care Model could Help Us Cope wit…

As the UK government looks for an exit strategy to Britain's COVID-19 lockdown a nanomedicine expert from The University of Manchester believes a care model usually applied to cancer patients...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...